BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 8630943)

  • 1. ErbB-2 expression is correlated with poor prognosis for patients with osteosarcoma.
    Onda M; Matsuda S; Higaki S; Iijima T; Fukushima J; Yokokura A; Kojima T; Horiuchi H; Kurokawa T; Yamamoto T
    Cancer; 1996 Jan; 77(1):71-8. PubMed ID: 8630943
    [TBL] [Abstract][Full Text] [Related]  

  • 2. COPS3 amplification and clinical outcome in osteosarcoma.
    Yan T; Wunder JS; Gokgoz N; Gill M; Eskandarian S; Parkes RK; Bull SB; Bell RS; Andrulis IL
    Cancer; 2007 May; 109(9):1870-6. PubMed ID: 17366602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of P-glycoprotein, HER-2/ErbB-2, p53, and Bcl-2 in primary tumor and metachronous lung metastases in patients with high-grade osteosarcoma.
    Ferrari S; Bertoni F; Zanella L; Setola E; Bacchini P; Alberghini M; Versari M; Bacci G
    Cancer; 2004 May; 100(9):1936-42. PubMed ID: 15112275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrated assessment of potential value of erbB-2 amplification or expression status as novel therapy target in Chinese children and adolescents with osteosarcoma.
    Shang J; Bi ZG; Ji HF; Wang WB
    Chin Med J (Engl); 2009 Jul; 122(13):1521-4. PubMed ID: 19719941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. C-erbB-2 expression and prognostic significance in osteosarcoma.
    Yalçin B; Gedikoğlu G; Kutluk T; Varan A; Akyüz C; Büyükpamukçu M
    Pediatr Blood Cancer; 2008 Aug; 51(2):222-7. PubMed ID: 18421709
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of vascular endothelial growth factor-C and its receptor in osteosarcomas.
    Park HR; Min K; Kim HS; Jung WW; Park YK
    Pathol Res Pract; 2008; 204(8):575-82. PubMed ID: 18440723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aberrant expression of the human epidermal growth factor receptor 2 oncogene is not a common feature in osteosarcoma.
    Baumhoer D; Smida J; Specht K; Bink K; Quintanilla-Martinez L; Rosemann M; Siggelkow H; Nathrath WB; Atkinson MJ; Bielack S; Jundt G; Nathrath M
    Hum Pathol; 2011 Jun; 42(6):859-66. PubMed ID: 21292304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutation spectrum of the retinoblastoma gene in osteosarcomas.
    Wadayama B; Toguchida J; Shimizu T; Ishizaki K; Sasaki MS; Kotoura Y; Yamamuro T
    Cancer Res; 1994 Jun; 54(11):3042-8. PubMed ID: 8187094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HER2 amplification and overexpression is not present in pediatric osteosarcoma: a tissue microarray study.
    Somers GR; Ho M; Zielenska M; Squire JA; Thorner PS
    Pediatr Dev Pathol; 2005; 8(5):525-32. PubMed ID: 16211448
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased expression of membrane-type matrix metalloproteinase-1 is correlated with poor prognosis in patients with osteosarcoma.
    Uchibori M; Nishida Y; Nagasaka T; Yamada Y; Nakanishi K; Ishiguro N
    Int J Oncol; 2006 Jan; 28(1):33-42. PubMed ID: 16327977
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Absence of HER2/neu gene expression in osteosarcoma and skeletal Ewing's sarcoma.
    Thomas DG; Giordano TJ; Sanders D; Biermann JS; Baker L
    Clin Cancer Res; 2002 Mar; 8(3):788-93. PubMed ID: 11895910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of c-erbB-2 oncoprotein in muscle-invasive bladder carcinoma: relationship with gene amplification, clinicopathological parameters and prognostic outcome.
    Krüger S; Weitsch G; Büttner H; Matthiensen A; Böhmer T; Marquardt T; Sayk F; Feller AC; Böhle A
    Int J Oncol; 2002 Nov; 21(5):981-7. PubMed ID: 12370744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation between c-erbB-2 amplification and risk of recurrent disease in node-negative breast cancer.
    Paterson MC; Dietrich KD; Danyluk J; Paterson AH; Lees AW; Jamil N; Hanson J; Jenkins H; Krause BE; McBlain WA
    Cancer Res; 1991 Jan; 51(2):556-67. PubMed ID: 1670762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Absence of a telomere maintenance mechanism as a favorable prognostic factor in patients with osteosarcoma.
    Ulaner GA; Huang HY; Otero J; Zhao Z; Ben-Porat L; Satagopan JM; Gorlick R; Meyers P; Healey JH; Huvos AG; Hoffman AR; Ladanyi M
    Cancer Res; 2003 Apr; 63(8):1759-63. PubMed ID: 12702558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidermal growth factor receptor expression in high-grade osteosarcomas is associated with a good clinical outcome.
    Kersting C; Gebert C; Agelopoulos K; Schmidt H; van Diest PJ; Juergens H; Winkelmann W; Kevric M; Gosheger G; Brandt B; Bielack S; Buerger H
    Clin Cancer Res; 2007 May; 13(10):2998-3005. PubMed ID: 17505002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of allelic imbalance at the c-kit gene locus and c-kit overexpression by immunohistochemistry in pediatric osteosarcomas.
    Entz-Werlé N; Marcellin L; Gaub MP; Guerin E; Schneider A; Berard-Marec P; Kalifa C; Brugiere L; Pacquement H; Schmitt C; Tabone MD; Jeanne-Pasquier C; Terrier P; Dijoud F; Oudet P; Lutz P; Babin-Boilletot A
    J Clin Oncol; 2005 Apr; 23(10):2248-55. PubMed ID: 15800315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinicopathologic analysis of HER-2/neu immunoexpression among various histologic subtypes and grades of osteosarcoma.
    Kilpatrick SE; Geisinger KR; King TS; Sciarrotta J; Ward WG; Gold SH; Bos GD
    Mod Pathol; 2001 Dec; 14(12):1277-83. PubMed ID: 11743051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative assessment of HER2/neu expression by real-time PCR and fluorescent in situ hybridization analysis in low-grade osteosarcoma.
    Lee WI; Bacchni P; Bertoni F; Maeng YH; Park YK
    Oncol Rep; 2004 Jul; 12(1):125-8. PubMed ID: 15201972
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amplification of c-erbB2 oncogene: a major prognostic indicator in uterine serous papillary carcinoma.
    Santin AD; Bellone S; Van Stedum S; Bushen W; Palmieri M; Siegel ER; De Las Casas LE; Roman JJ; Burnett A; Pecorelli S
    Cancer; 2005 Oct; 104(7):1391-7. PubMed ID: 16116605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vascular endothelial growth factor expression in untreated osteosarcoma is predictive of pulmonary metastasis and poor prognosis.
    Kaya M; Wada T; Akatsuka T; Kawaguchi S; Nagoya S; Shindoh M; Higashino F; Mezawa F; Okada F; Ishii S
    Clin Cancer Res; 2000 Feb; 6(2):572-7. PubMed ID: 10690541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.